Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients

NCT01416402 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia
Gout

Interventions

DRUG: Arhalofenate
DRUG: Febuxostat
DRUG: Colchicine

Sponsor

Gilead Sciences